The Clinical Analysis on Early Diabetic Nephropathy by Applying Losartan

YANG Wei,YANG Li,WU Shao-rong
DOI: https://doi.org/10.3969/j.issn.1671-301X.2007.03.007
2007-01-01
Abstract:Objective:To estimate the effect and mechanism of angiotensin receptor antagonists on early diabetic nephropathy by applying losartan. Methods: Early diabetic nephropathy patients were randomly divided into two groups: diabetic nephropathy control (DN),Losartan treatment group (DL). At the end of the 4th and 8th week,mean glomerular volume (MGV) and fractional mesangial area (FMA) were calculated by medical image analysis system. The mRNA expression of TGF-β1,CTGF,PAI-1 and FN were detected by quantitative real time RT-PCR. Urinary albumin excretion rate (UAER),as well as serum creatinine (SCr) and creatinine clearance rate (CCr),was detected. Results: DN group urinary albumin (UAER) continued to rise; serum creatinine (SCr), and renal TGF-β1, CTGF. FN and PAI-1 mRNA expression was significantly increased, and creatinine clearance (CCr) has started to decline. DL group were significantly more improvement. The difference between the two groups was significant. Conclusion: Losartan reduced kidney cytokine gene expression that may play role in kidney protection.
What problem does this paper attempt to address?